Press Release Archive - 2013

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

20 Feb 2013

Antares Pharma to Participate in the 2013 RBC Capital Markets’ Healthcare Conference
READ  

27 Feb 2013

Antares Pharma Announces FDA Acceptance of New Drug Application for OTREXUP
READ  

13 Mar 2013

Antares Pharma Reports Fourth Quarter and 2012 Full Year Operating and Financial Results
READ  

03 Apr 2013

Antares Pharma Announces First Shipment of Commercial Vibex Auto-Injector Devices to TEVA
READ  

05 Apr 2013

Antares Pharma Announces Notice of Allowance For New Patent on Vibex Quick Shot Device
READ  

16 Apr 2013

Antares Pharma Announces the Issuance of a New Patent on Vibex Device Platform
READ  

01 May 2013

Antares Pharma to Host First Quarter 2013 Operating and Financial Results Conference Call
READ  

08 May 2013

Antares Pharma Reports First Quarter Financial 2013 Operating and Financial Results
READ  

09 May 2013

Antares Pharma to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
READ  

23 May 2013

Antares Pharma Welcomes Marvin Samson to Board of Directors
READ  

24 May 2013

Antares Pharma to Present at The Deutsche Bank Securities INC. 38TH Annual Health Care Conference
READ  

29 May 2013

Antares Pharma to Present at the Jefferies 2013 Global Healthcare Conference
READ  

13 Jun 2013

Subcutaneous Self-Administered Methotrexate for Rheumatoid Arthritis Demonstrated Significantly Greater Bioavailability Over Current Standard of Care
READ  

27 Jun 2013

Antares Announces the Issuance of a New U.S. Patent for OTREXUP
READ  

30 Jul 2013

Antares Pharma Welcomes Robert P. Roche JR to Board of Directors
READ  

30 Jul 2013

Antares Pharma to Host Second Quarter 2013 Operating and Financial Results Conference Call
READ  

07 Aug 2013

Antares Pharma Reports Second Quarter 2013 Operating and Financial Results
READ  

16 Sep 2013

Antares Pharma Announces First Patients Dosed in VIBEX QST Study Evaluating Testosterone Deficient Males
READ  

14 Oct 2013

OTREXUP (METHOTREXATE) Injection Approved By FDA
READ  

25 Oct 2013

Antares Pharma Announces the Issuance of a New US Patent on the Vibex Device Platform
READ  

16 Oct 2013

Antares Announces Podium Presentation of Pivotal OTREXUP(METHOTREXATE) Data at American College of Rheumatology Annual Meeting
READ  

01 Nov 2013

Antares Pharma to Host Third Quarter 2013 Operating and Financial Results Conference Call
READ  

04 Nov 2013

Antares Pharma Appoints Dr. Bruce Freundlich as Senior Vice President
READ  

06 Nov 2013

Antares Pharma Reports Third Quarter 2013 Financial and Operating Results
READ  

14 Nov 2013

Antares Pharma Enters into an Exclusive U.S. Promotion and Marketing Agreement With LEO Pharma for Otrexup in Dermatology
READ  

15 Nov 2013

Antares Pharma To Present At The Jefferies 2013 Global Healthcare Conference
READ  

19 Nov 2013

Antares Pharma Appoints Dr. David Bergstrom Ph.D. as Senior Vice President of Pharmaceutical Development
READ  

26 Nov 2013

Antares Pharma Announces Additional U.S. Patent Protection for Otrexup
READ  

04 Dec 2013

Antares to Present at the Oppenheimer 24th Annual Healthcare Conference
READ  

20 Dec 2013

Antares Pharma Announces Notice of Allowance for New Patent on Reconstitutable Lyophilized Injectables
READ